Galvanize Therapeutics, Inc.

Sep 03, 2025

Galvanize Therapeutics raises $100 million in Oversubscribed Series C Financing to Transform the Treatment of Cancer and Chronic Lung Disease

Aug 15, 2025

Galvanize Announces First Patient Enrolled in the PROPEL Registry Evaluating Aliya® Pulsed Electric Field Ablation for Soft Tissue Lesions

Jul 02, 2024

Galvanize Appoints Executive Chairman and New Oncology-Focused Director to the Board of Directors

May 28, 2024

Galvanize Receives FDA Clearance for the INUMI Flex Endoscopic Needle, Expanding its Aliya® Pulsed Electric Field (PEF) Portfolio for Soft Tissue Ablation